<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03362580</url>
  </required_header>
  <id_info>
    <org_study_id>CHUB-ERM</org_study_id>
    <nct_id>NCT03362580</nct_id>
  </id_info>
  <brief_title>Prevalence and Risk Factors of Epiretinal Membrane in Diabetic and Non-diabetic Patients</brief_title>
  <official_title>Prevalence and Risk Factors of Epiretinal Membrane in Diabetic and Non-diabetic Patients: a Prospective, Cross-sectional and Comparative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laurence Postelmans</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brugmann University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Numerous terms have been used to describe epiretinal membrane (ERM): macular pucker,
      epimacular membrane, surface-wrinkling retinopathy, cellophane maculopathy and preretinal
      macular fibrosis. It is, by definition, a fibrocellular tissue found on the inner surface of
      the retina. It is semi-translucent and proliferates on or above the surface of the internal
      limiting membrane. It causes blurring and metamorphopsia, while mild cases are often
      asymptomatic.

      ERM presence can degrade the acuity and the quality of vision, thus affecting the quality of
      life. There is evidence that it also has an adverse impact to the treatment options for
      patients suffering from macular disorders. More specifically, regarding to diabetic
      retinopathy, ERM seems to have a bidirectional etiopathogenetic relationship with its course
      and complications.

      The aim of this study is to know the prevalence of ERM in the Brussel's population, the risk
      factors predisposing to ERM formation and if diabetic patients have a significantly higher
      prevalence of ERM in comparison to general population.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 12, 2017</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Age</measure>
    <time_frame>First standard of care consultation, up to 3 months</time_frame>
    <description>Age</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Gender</measure>
    <time_frame>First standard of care consultation, up to 3 months</time_frame>
    <description>Gender</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Population sub-type</measure>
    <time_frame>First standard of care consultation, up to 3 months</time_frame>
    <description>Population sub-type: Caucasian, African, Asian, Indian, American or Other</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diabetes type (for group A)</measure>
    <time_frame>First standard of care consultation, up to 3 months</time_frame>
    <description>Diabetes type (for group A)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diabetic Retinopathy classification</measure>
    <time_frame>First standard of care consultation, up to 3 months</time_frame>
    <description>Diabetic Retinopathy classification, if diagnosed (according to the Early Treatment of Diabetic Retinopathy Study (ETDRS) classification)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of medical treatment of diabetes</measure>
    <time_frame>First standard of care consultation, up to 3 months</time_frame>
    <description>Duration of medical treatment of diabetes (measured in months)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>HbA1C (Glycated Haemoglobin) rate</measure>
    <time_frame>First standard of care consultation, up to 3 months</time_frame>
    <description>HbA1C rate (according to recent blood test)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Smoking status</measure>
    <time_frame>First standard of care consultation, up to 3 months</time_frame>
    <description>Smoking status</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Previous cataract surgery</measure>
    <time_frame>First standard of care consultation, up to 3 months</time_frame>
    <description>Previous cataract surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diagnose of ERM</measure>
    <time_frame>First standard of care consultation, up to 3 months</time_frame>
    <description>Diagnose of ERM</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Educational level</measure>
    <time_frame>First standard of care consultation, up to 3 months</time_frame>
    <description>Educational level</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Epiretinal Membrane</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <description>Patients diagnosed with diabetes mellitus, type 1 or type 2, aged 15 years or older</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <description>Patients non-diagnosed with diabetes mellitus, aged 15 years or older</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Slit lamp examination</intervention_name>
    <description>The slit lamp is an instrument consisting of a high-intensity light source that can be focused to shine a thin sheet of light into the eye.Examination performed without pupil dilatation.</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Undilated 7-field color fundus photography</intervention_name>
    <description>Undilated 7-field color fundus photography with Cobra fundus camera. The examination will be done without pupil dilatation; but in case of very small pupils one drop of tropicamide will be instilled, after anterior segment observation with the slit lamp. Two ophthalmologists will assess fundus photos and OCT (Spectral domain optical coherence tomography) frames, to determine whether or not an ERM is present.</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Color scan</intervention_name>
    <description>Multicolor photo. The examination will be done without pupil dilatation; but in case of very small pupils one drop of tropicamide will be instilled, after anterior segment observation with the slit lamp.</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spectral domain optical coherence tomography</intervention_name>
    <description>Spectral domain optical coherence tomography (OCT) with Heidelberg Retina Tomography device. The examination will be done without pupil dilatation; but in case of very small pupils one drop of tropicamide will be instilled, after anterior segment observation with the slit lamp.Two ophthalmologists will assess fundus photos and OCT frames, to determine whether or not an ERM is present.</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects examined in the general or diabetes screening consultations of the Ophtalmology
        Department of the CHU Brugmann Hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -Subjects examined in the general or diabetes screening consultations of the Ophthalmology
        Department of the CHU Brugmann Hospital

        Exclusion Criteria:

          -  Women pregnant or breast-feeding

          -  Hypersensitivity to tropicamide

          -  Any macular pathology other than diabetic maculopathy

          -  Prior retinal photocoagulation

          -  Prior intravitreal injection

          -  Prior retinal surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurence Postelmans, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Brugmann</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dimitrios Panagiotou, MD</last_name>
    <phone>3224772407</phone>
    <email>panagiotoudim@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laurence Postelmans, MD</last_name>
    <email>Laurence.Postelmans@chu-brugmann.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Brugmann</name>
      <address>
        <city>Brussels</city>
        <zip>1020</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence Postelmans, MD</last_name>
      <email>laurence.postelmans@chu-brugmann.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2017</study_first_submitted>
  <study_first_submitted_qc>November 29, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 5, 2017</study_first_posted>
  <last_update_submitted>January 18, 2018</last_update_submitted>
  <last_update_submitted_qc>January 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Brugmann University Hospital</investigator_affiliation>
    <investigator_full_name>Laurence Postelmans</investigator_full_name>
    <investigator_title>Head of clinic</investigator_title>
  </responsible_party>
  <keyword>Epiretinal Membrane</keyword>
  <keyword>Diabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epiretinal Membrane</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

